The clinicopathologic significance of FOXC1 in BRCA-mutant breast cancer.

被引：0
|
作者：
Choi, Michael Phillip
Cui, Xiaojiang
Dadmanesh, Farnaz
Liles, Georgia
Zhang, Xiao
Karlan, Beth
Glullano, Armando E.
Amersi, Farin F.
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Santa Monica, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.1556
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1556
引用
收藏
页数：1
相关论文
共 50 条
  • [1] FOXC1 Mediates the Basal Phenotype in BRCA1-mutant Breast Cancer
    Johnson, J.
    Choi, M.
    Han, B.
    Qu, Y.
    Dadmanesh, F.
    Zhang, X.
    Karlan, B.
    Giuliano, A. E.
    Cui, X.
    Amersi, F.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S57 - S57
  • [2] Genetics: BRCA-mutant breast/ovarian cancer revealed
    Sidaway P.
    Nature Reviews Clinical Oncology, 2017, 14 (9) : 524 - 524
  • [3] Olaparib for BRCA-mutant pancreatic cancer
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (08): : 584 - 584
  • [4] FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer
    Ray, Partha S.
    Wang, Jinhua
    Qu, Ying
    Sim, Myung-Shin
    Shamonki, Jaime
    Bagaria, Sanjay P.
    Ye, Xing
    Liu, Bingya
    Elashoff, David
    Hoon, Dave S.
    Walter, Michael A.
    Martens, John W.
    Richardson, Andrea L.
    Giuliano, Armando E.
    Cui, Xiaojiang
    CANCER RESEARCH, 2010, 70 (10) : 3870 - 3876
  • [5] FOXC1 is a potential prognostic marker with functional significance in basal-like breast cancer
    Wang, Jinhua
    Ray, Partha
    Qu, Ying
    Sim, Myung-Shin
    Shamonki, Jaime
    Bagaria, Sanjay
    Ye, Xing
    Liu, Bingya
    Walter, Michael
    Hoon, Dave
    Giuliano, Armando
    Cui, Xiaojiang
    CANCER RESEARCH, 2010, 70
  • [6] Contribution of FOXC1 to the progression and metastasis and prognosis of human colon cancer.
    Li, Dawei
    Li, Qingguo
    Zhuo, Changhua
    Xu, Ye
    Cai, Sanjun
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [7] Diagnostic and prognostic significance of FOXC1 expression in basal-like triple negative breast cancer
    Ray, P. S.
    Wang, J.
    Qu, Y.
    Shin-Sim, M.
    Shamonki, J.
    Bagaria, S. P.
    Liu, B.
    Elashoff, D.
    Hoon, D. S.
    Giuliano, A. E.
    Cui, X.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S21 - S21
  • [8] FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells
    Du, Juan
    Li, Lin
    Ou, Zhouluo
    Kong, Chenfei
    Zhang, Yu
    Dong, Zhixiong
    Zhu, Shan
    Jiang, Hao
    Shao, Zhimin
    Huang, Baiqu
    Lu, Jun
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (01) : 65 - 73
  • [9] FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells
    Juan Du
    Lin Li
    Zhouluo Ou
    Chenfei Kong
    Yu Zhang
    Zhixiong Dong
    Shan Zhu
    Hao Jiang
    Zhimin Shao
    Baiqu Huang
    Jun Lu
    Breast Cancer Research and Treatment, 2012, 131 : 65 - 73
  • [10] FOXC1 induces cisplatin resistance through enhancer activation in bladder cancer.
    Lu, Yi-Tsung
    Xu, Tong
    Hsieh, Tien-Chan
    Iqbal, Maheen
    Luo, Zhifei
    Farnham, Peggy J.
    Rhie, Suhn K.
    Goldkorn, Amir
    CANCER RESEARCH, 2021, 81 (13)
12345